Biomarker Discovery in Exhaled Breath Condensate (EBC) to discriminate pts with lung cancer CS I-IV from pts with COPD or lung fibrosis and healthy controls.

Category Primary study
Registry of TrialsGerman Clinical Trials Register
Year 2024
This article has no abstract
Epistemonikos ID: 3fa450bef21bb1dc4de93897dc715b1dbdad3129
First added on: Apr 10, 2025